Drug
Pipe 791 Dose A
Pipe 791 Dose A: highest development phase Phase 2, developed by Contineum Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Contineum Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PIPE-791 Dose A NCT07284459 | Phase 2 | Idiopathic Pulmonary Fibrosis |
Latest
No recent events.
Follow Pipe 791 Dose A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.